KeyBanc on Repligen (RGEN): '4Q25 Momentum Points to Conservative 2026' Feb 25, 2026 08:32AM
Repligen (RGEN) Tops Q4 EPS by 5c; offers guidance Feb 24, 2026 07:36AM
Repligen (RGEN) PT Raised to $200 at UBS on Bioprocessing Recovery Jan 16, 2026 09:37AM
Halozyme Therapeutics (HALO) PT Raised at TD Cowen; 'One of Our Top Picks for 2026' Jan 8, 2026 09:30AM
Repligen names Dr. Martin Madaus as board chair as Tony Hunt retires Jan 6, 2026 07:31AM
View Older Stories

Dec 16, 2025 07:30AM Repligen launches three new chromatography resins for gene therapy
Dec 8, 2025 07:11AM KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
Nov 12, 2025 08:43AM Repligen (RGEN): No reason to change bullish stance on stock, says Stifel
Oct 28, 2025 01:41PM Repligen (RGEN) PT Raised to $160 at Jefferies
Oct 28, 2025 07:33AM Repligen (RGEN) Tops Q3 EPS by 4c ; Offers Guidance
Oct 1, 2025 03:55AM HSBC Starts Repligen (RGEN) at Buy
Sep 23, 2025 07:29AM KeyBanc Takeaways from This Year's BioProcess International Conference
Sep 23, 2025 07:26AM KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Sep 22, 2025 06:02AM Evercore ISI Upgrades Repligen (NASDAQ: RGEN) to Outperform (correction)
Sep 17, 2025 07:53AM TD Cowen Reiterates Buy Rating on Repligen (RGEN), Still a Top Pick
Sep 16, 2025 08:39AM Stifel Reiterates Buy Rating on Repligen (RGEN)
Sep 11, 2025 04:06PM Repligen (RGEN) PT Lowered to $135 at Jefferies
Sep 3, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Repligen (RGEN)
Jul 30, 2025 08:47AM KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Jul 29, 2025 07:32AM Repligen (RGEN) Misses Q2 EPS by 2c; offers guidance
Jun 24, 2025 06:18AM Barclays Starts Repligen (RGEN) at Overweight
Jun 16, 2025 08:02AM 908 Devices (MASS) Appoints Christopher D. Brown to its Board of Directors
Jun 9, 2025 03:28PM Maravai LifeSciences (MRVI) on watch on vague chatter following CEO change
May 30, 2025 12:34PM Repligen (RGEN) Trading LOD, Down 3.6pct
Apr 29, 2025 04:03PM Repligen (RGEN) PT Lowered to $940 at Truist Securities
Apr 29, 2025 03:58PM Repligen (RGEN) PT Lowered to $914 at Jefferies
Apr 29, 2025 02:54PM Repligen (RGEN) PT Lowered to $190 at JPMorgan, 'All in, we applaud RGEN’s consistent performance during the bioprocessing recovery'
Apr 29, 2025 07:33AM Repligen (RGEN) Tops Q1 EPS by 4c, provides guidance
Mar 17, 2025 04:05PM Evercore ISI Starts Repligen (RGEN) at In Line
Mar 4, 2025 09:50AM Leerink Partners Reiterates Outperform Rating on Repligen (RGEN)
Mar 4, 2025 07:32AM Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)
Feb 28, 2025 10:02AM TD Cowen Issues Stock Conclusions Following Bioproduction Market Survey
Feb 24, 2025 08:42AM Benchmark Reiterates Hold Rating on Repligen (RGEN)
Feb 21, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Repligen (RGEN)
Feb 21, 2025 06:37AM Repligen (RGEN) PT Raised to $170 at Canaccord Genuity
Feb 21, 2025 04:35AM KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Feb 20, 2025 01:57PM Repligen (RGEN) PT Raised to $165 at Jefferies
Feb 20, 2025 07:38AM Repligen (RGEN) Tops Q4 EPS by 3c ; Offers Guidance
Feb 10, 2025 05:30AM TD Cowen Starts Repligen (RGEN) at Buy
Jan 6, 2025 07:30AM Repligen (RGEN) Launches the CTech SoloVPE PLUS System
Dec 16, 2024 04:12PM Canaccord Genuity Starts Repligen (RGEN) at Hold
Dec 9, 2024 07:36AM Repligen (RGEN) Launches Novel AVIPure dsRNA Resin in OPUS® Pre-packed Columns
Nov 14, 2024 06:04AM Wolfe Research Starts Repligen (RGEN) at Peerperform
Nov 12, 2024 02:45PM KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Nov 12, 2024 07:35AM Repligen (RGEN) Tops Q3 EPS by 10c ; Offers Guidance
Sep 18, 2024 04:38PM After-hours movers: Steelcase, Hess Midstream Partners, Repligen
Sep 18, 2024 04:25PM Repligen (RGEN) Reports Non-Reliance on Previously Issued Financial Statements
Aug 19, 2024 07:47AM KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Aug 16, 2024 02:53PM Stifel on Repligen (RGEN) M&A Speculation with Maravai (MRVI)
Aug 16, 2024 12:00PM Midday movers: H&R Block, Maravai LifeSciences rise; Applied Materials falls
Aug 16, 2024 11:40AM Repligen (RGEN) Has Approached Maravai Lifesciences (MRVI) with an Acquisition Offer - Reuters
Jul 30, 2024 07:33AM Repligen (RGEN) Reports In-Line Q2 EPS, provides guidance
Jul 29, 2024 04:00PM Repligen (RGEN) to Acquire Chromatography Innovator Tantti
Jul 15, 2024 04:08PM Repligen (RGEN) discoveres unauthorized third party had accessed certain files on the Company’s information systems
Jul 2, 2024 10:27AM Deutsche Bank New Quarterly Feature Called 'Fresh Money List' Picks, 17 Additions
View Older Stories